Cochlear | COH - Selling And Administration Expenses

Stock Price
266.76
Daily Change
0.61 0.23%
Monthly
2.40%
Yearly
-14.62%
Q1 Forecast
263.64

Cochlear reported AUD234.95M in Selling and Administration Expenses for its fiscal semester ending in June of 2025.





Selling And Administration Expenses Change Date
Ansell USD 267.2M 8.5M Jun/2025
Avita Medical AUD 20.98M 253K Jun/2025
Cochlear AUD 234.95M 235.05M Jun/2025
CSL USD 727M 453M Jun/2025
Fisher Paykel Healthcare NZD 285.5M 11.6M Dec/2025
Healius AUD 393.4M 378.35M Dec/2024
Integral Diagnostics AUD 169.98M 18.73M Jun/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Mesoblast USD 18.85M 7.99M Jun/2025
Monash IVF AUD 6.32M 82.33M Jun/2025
Nanosonics AUD 26.85M 23.41M Jun/2025
Polynovo AUD 21.13M 18.27M Jun/2024
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
Regis Healthcare AUD 505.42M 18.5M Dec/2024
ResMed USD 275.7M 16.51M Dec/2025
Sigma Healthcare AUD 134.77M 9.73M Dec/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024